EXPLORING
A BRIGHT LIFE
Development Projects
Focused Areas of Technology
Ultrasound Enhancing Agents
Trust Bio-sonics is a leading pharmaceutical R&D company specializing in lipid microsphere technology. With proprietary liposome formation technology, we provide microbubble injectable formulations with small particle sizes and high stability.
Our lead candidate, TBS-002, is an ultrasound enhancing agent designed to improve the sensitivity of medical ultrasound imaging for blood flow visualization, aiding clinicians in the precise diagnosis of cardiovascular diseases and cancer. Currently, Trust Bio-sonics' leading candidate, TBS-002, is in late-stage clinical development (Phase 3 in the U.S. and Taiwan).
Ultrasound-Mediated Drug Delivery
Ultrasound-mediated drug delivery is a rapid and efficient controlled drug release technology. This approach leverages the cavitation effect generated by microbubble formulations under ultrasound exposure to enhance vascular permeability in the targeted area, facilitating drug penetration into local tissues and increasing drug accumulation.
This ultimately improves therapeutic efficacy and offers a groundbreaking opportunity for tackling hard-to-treat diseases. The technology can be applied to the targeted delivery of various drug types, including chemotherapeutics, small molecules, biologics, such as immunosuppressants, and gene therapies.